We report on the differential evolution of CD8+ T-cell response to unique SARS-CoV-2 epitopes (SC2-unique) and SARS-CoV-2 epitopes that are shared with other coronaviruses (CoV-common) in patients with critical and non-critical COVID-19 presentation. The gene discussed is CD8A; the disease is COVID-19.